Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis
Amirhossein Hessami, Amir Shamshirian, Keyvan Heydari, et al.
The American Journal of Emergency Medicine (2020) Vol. 46, pp. 382-391
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Features, Evaluation and Treatment Coronavirus (COVID-19)
Marco Cascella, Michael Rajnik, Arturo Cuomo, et al.
StatPearls (2020)
Closed Access | Times Cited: 2796
A systematic review of pregnant women with COVID-19 and their neonates
Mona Mirbeyk, Amene Saghazadeh, Nima Rezaei
Archives of Gynecology and Obstetrics (2021)
Open Access | Times Cited: 130
Covid-19 and non-communicable diseases: evidence from a systematic literature review
Zlatko Nikoloski, Ada Alqunaibet, Rasha Abdulrahman Alfawaz, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 116
Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank
Eric Yuk Fai Wan, Sukriti Mathur, Ran Zhang, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 8, pp. 1718-1727
Closed Access | Times Cited: 84
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
The role of vitamin D in the age of COVID‐19: A systematic review and meta‐analysis
Roya Ghasemian, Amir Shamshirian, Keyvan Heydari, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 85
COVID-19 and Its Global Economic Impact
Zahra Kolahchi, Manlio De Domenico, Lucina Q. Uddin, et al.
Advances in experimental medicine and biology (2021), pp. 825-837
Closed Access | Times Cited: 79
Knowledge About COVID-19, Beliefs and Vaccination Acceptance Against COVID-19 Among High-Risk People in Ho Chi Minh City, Vietnam
Giao Huynh, Tap Van Nguyen, Dung Dang Nguyen, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 1773-1780
Open Access | Times Cited: 78
The relationship of serum testosterone levels with the clinical course and prognosis of COVID‐19 disease in male patients: A prospective study
Ahmet Emre Cinislioğlu, Nazan Cinislioğlu, Şaban Oğuz Demirdöğen, et al.
Andrology (2021) Vol. 10, Iss. 1, pp. 24-33
Open Access | Times Cited: 74
Cardiovascular disease (CVD): assessment, prediction and policy implications
Shazia Rehman, Erum Rehman, Muhammad Ikram, et al.
BMC Public Health (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 71
Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis
Fatemeh Pourali, Mahdi Afshari, Reza Alizadeh‐Navaei, et al.
New Microbes and New Infections (2020) Vol. 37, pp. 100743-100743
Open Access | Times Cited: 69
Effect of Coronary Artery Disease on COVID-19—Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis
Łukasz Szarpak, Małgorzata Mierzejewska, Jonasz Jurek, et al.
Biology (2022) Vol. 11, Iss. 2, pp. 221-221
Open Access | Times Cited: 41
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 21
Anosmia: a missing link in the neuroimmunology of coronavirus disease 2019 (COVID-19)
Niloufar Yazdanpanah, Amene Saghazadeh, Nima Rezaei
Reviews in the Neurosciences (2020) Vol. 31, Iss. 7, pp. 691-701
Open Access | Times Cited: 55
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Rui‐Sheng Wang, Joseph Loscalzo
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1374-1386
Open Access | Times Cited: 16
Diverse origins of fibrinolytic enzymes: A comprehensive review
Chinmay Hazare, Prashant Bhagwat, Suren Singh, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26668-e26668
Open Access | Times Cited: 5
COVID-19 Associated Cardiovascular Disease—Risks, Prevention and Management: Heart at Risk Due to COVID-19
Andrew Kemerley, Abhishek Gupta, Mahesh Thirunavukkarasu, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 3, pp. 1904-1920
Open Access | Times Cited: 5
Predictors of Mortality in Critically Ill COVID‐19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy
Višeslav Popadić, Slobodan Klašnja, Nataša Milić, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 36
Association between cardiovascular disease, cardiovascular drug therapy, and in-hospital outcomes in patients with COVID-19: data from a large single-center registry in Poland
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, et al.
Kardiologia Polska (2021) Vol. 79, Iss. 7-8, pp. 773-780
Open Access | Times Cited: 33
Guaiazulene and related compounds: A review of current perspective on biomedical applications
Wasim Akram, Priti Tagde, Sakeel Ahmed, et al.
Life Sciences (2023) Vol. 316, pp. 121389-121389
Closed Access | Times Cited: 14
Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors
Zhiyin Yu, Jianping Huang, Jing Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review
Carles Vilaplana-Carnerero, Maria Giner‐Soriano, Ángela Domı́nguez, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1206-1206
Open Access | Times Cited: 14
Multimorbidity and SARS-CoV-2–Related Outcomes: Analysis of a Cohort of Italian Patients
Alberto Catalano, Lucia Dansero, Winston Gilcrease, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e41404-e41404
Open Access | Times Cited: 12
Cardiovascular disease risk after a SARS-CoV-2 infection: A systematic review and meta-analysis
Karla Romero Starke, Pauline Kaboth, Natalie Rath, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106215-106215
Open Access | Times Cited: 4
Proportion and mortality of Iranian diabetes mellitus, chronic kidney disease, hypertension and cardiovascular disease patients with COVID-19: a meta-analysis
Hamid Mirjalili, Seyed Alireza Dastgheib, Seyed Hossein Shaker, et al.
Journal of Diabetes & Metabolic Disorders (2021) Vol. 20, Iss. 1, pp. 905-917
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top